Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: nestegg who wrote (8041)	12/13/1998 5:49:00 PM
From: Bluegreen	Respond to of 17367

I know I keep repeating myself, but that was advice given to Xoma from Lehman Bros. Whether you like it or not the company you invested in gave Lehman Bros. five hundred grand for their opinion. I for one tend to take advice from experts. I chose not to believe there is sinister plots behind brokerage houses or Xoma. I was skeptical at first but the experts McCamant, Murphy, Taipan and Prohost did not raise any red flags over the deal so I voted yes. These four experts are screaming the same thing at the same time about Xoma and possible products. Asking the same questions or raising the same doubts doesn't change whether or not there is a vote. If you don't believe it is a good idea vote no! Only my opinions.

To: nestegg who wrote (8041)	12/13/1998 6:38:00 PM
From: aknahow	Read Replies (3) \| Respond to of 17367

Friends, Romans, countrymen and you too nestegg, that is a good question. I don't blame you for not having read all the post. There is something called fair value of assets. Changing domicile makes sense only when you are starting out. There is a tax imposed upon change of domicile based upon the fair value of a companies assets at the time of the change. I believe this was the only legitimate question raised by the XOMA bashers on Yahoo. When the prospectus answered it they kept quiet, until they had an excuse to begin again. The answer explains why everyone does not do it. Nestegg, welcome back. I love this idea. Wish I was working for Lehman because this would be a real pleasure to present to many corporations that have operations abroad and are not yet profitable. biotechs happen to fit into this concept very well as a drug that works on U.S. residents, probably works on others also. <g> It is interesting to me to see how difficult this domicile concept seems to be for some to accept. I just hope that those that don't like it own few shares, or are short and own no shares.